BioSpace News Archive

Sierra Oncology, Inc. announced that Dr. Nick Glover, President and Chief Executive Officer, will present an overview of the company entitled “Building Momentum for Patients with Myelofibrosis” at the Jefferies 2019 London Healthcare Conference in London, United Kingdom.

The FDA has assigned a Prescription Drug User Fee Act goal date of August 22, 2020 and indicated that it is currently planning to hold a Cardiovascular and Renal Drugs Advisory Committee meeting to discuss the application.

BD announced that it will present at the Jefferies 2019 London Healthcare Conference on Thursday, November 21, 2019, at 6:20 a.m. ET.

DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) (“DelMar” or the “Company”), a biopharmaceutical company focused on the development of new cancer therapies, announced its financial results for the quarter ended September 30, 2019.

Blueprint Medicines Corporation (NASDAQ: BPMC), a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, today announced that Jeff Albers, Blueprint Medicines’ Chief Executive Officer, will present a company overview at the Jefferies 2019 London Healthcare Conference in London

The National Institute of Allergy and Infectious Diseases (NIAID) has awarded Integral Molecular a contract (75N93019C00073) which will provide up to $5.5M over the next five years to define antibody responses to pathogenic viruses including Zika, Marburg and equine encephalitis viruses (EEV), aiding the discovery of vaccines and therapeutics against these currently untreatable and often lethal viruses.

Other Company Research Demonstrates the Value of Diagnostic Insights in Early Cardiovascular Disease Detection in Clinical and Workplace Settings

A new theory proposes that consciousness is an intrinsic feature of magnetic fields.

SetPoint Medical, a clinical-stage bioelectronic medicine company developing therapy for chronic autoimmune diseases, today announced that Murthy Simhambhatla, Ph.D., President and Chief Executive Officer, is scheduled to present at the 13th annual Canaccord Genuity Medical Technologies & Diagnostics Forum, being held November 21, 2019 in New York, New York.

Viome, a mission-driven company aiming to improve people’s health based on individual biology, today announced a partnership with GSK, the world’s leading vaccine company, to increase understanding of chronic diseases and a potential role for vaccines.